BI 671800 ED

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 671800 ED, covering 2022-05-31 to 2022-05-31. Get the full timeline:

Most recent: Clinical Trial Update: BI 671800 ED in Steroid-naive Asthmatic Patients [Phase 2]